MMJ PhytoTech Limited (ASX:MMJ) is pleased to note the attached media release by Weed Me Inc confirming that it has obtained a cultivation licence under the Access to Cannabis for Medical Purposes Regulations from Health Canada.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to note the attached press release by Cannabis Access, the medical cannabis access portal for Australian healthcare professionals, announcing the appointment of Dr Sanjay Nijhawan as Medical Director.
Oventus Medical Ltd (ASX:OVN) announces its Appendix 4C Report for the three-month period ending 31 March 2018 (Q3 FY2018) and is pleased to provide a review of progress made during the quarter.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce that it has invested CAD$1 million for an approximate 1.6% shareholding (before the future exercise of options, warrants and other convertible securities) in privately held Fire & Flower Inc..
MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce that it has entered into a strategic alliance with Calgary-based Target Capital Inc., trading as CBi2 Capital (CVE:TCI) (CNSX:TCI).
MMJ PhytoTech Limited (ASX:MMJ) provides an operations update for its 100%-owned subsidiary PhytoTech Therapeutics Limited.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce that it has rebranded to "MMJ" and relaunched its website.
